![]()
A) The ethics of cattle farming practices. B) The import of organic beef products. C) The use of growth hormones in beef production. D) The spread of bovine spongiform encephalopathy.
A) 1989 B) 2003 C) 1980 D) 1997
A) European Federation of Animal Health B) European Parliament C) Council of Agriculture Ministers D) World Trade Organization (WTO)
A) estradiol-17β B) testosterone C) progesterone D) zeranol
A) Italy and France B) Ireland and Belgium C) Canada and the United States D) Germany and the United Kingdom
A) Animal welfare standards. B) Environmental impact of cattle farming. C) Economic protection of European farmers. D) Health and safety concerns.
A) trenbolone acetate B) diethylstilbestrol C) zeranol D) melengestrol acetate
A) Discovery of illegal hormones in school lunches. B) Protests by organic farmers against beef imports. C) Mass death of cattle due to hormonal imbalance. D) Discovery of premature puberty in schoolchildren.
A) It passed by a vote of 177:1. B) It resulted in an immediate total ban. C) It was vetoed by the Council of Ministers. D) It was rejected by a wide margin.
A) When no consensus is reached between parties. B) When the product competes with domestic industry. C) When they present valid scientific evidence. D) When consumer groups demand it.
A) World Trade Organization B) European Consumers' Organisation (BEUC) C) European Federation of Animal Health (FEDESA) D) European Council of Agriculture Ministers
A) The UK-EU dispute concerns bovine spongiform encephalopathy. B) There is no difference between the two. C) The hormone controversy involves only Canada. D) The UK-EU dispute was resolved in 1989.
A) Edible offal. B) Ground beef. C) Dairy products. D) Leather goods.
A) To ensure cattle meat is safer for consumers. B) To comply with international trade laws. C) To increase the weight of beef significantly. D) For cost-reduction and therapeutic purposes.
A) A teratogen. B) A natural hormone. C) A food preservative. D) A growth promoter.
A) 12 July 1999 B) 12 July 1998 C) 13 February 1998 D) 13 February 1999
A) Risks from failing to observe good veterinary practice B) Risks from direct human consumption C) Risks from antibiotic resistance D) Risks from environmental degradation
A) 13 February 1998 B) 12 July 1999 C) 13 February 1999 D) 12 July 1998
A) US$116.8 million B) US$16.8 million C) US$116.8 billion D) US$1.168 million
A) Only partially B) No C) The report does not state D) Yes
A) Testosterone B) 17-beta estradiol C) Zeranol D) Progesterone
A) SPS equivalence principle B) Comparative advantage principle C) Precautionary principle D) Free trade principle
A) 18,500 tonnes B) 10,000 tonnes C) 35,000 tonnes D) 45,000 tonnes
A) 85% B) 75% C) 50% D) 95%
A) DS320 B) DS26 C) DS321 D) DS48
A) DS320 B) DS26 C) DS48 D) DS321 |